Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives $187.72 Consensus PT from Analysts
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eighteen research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average twelve-month price target among […]
More Stories
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives $604.05 Average Price Target from Analysts
Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty...
Old Republic International (NYSE:ORI) Stock Rating Upgraded by Wall Street Zen
Old Republic International (NYSE:ORI – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a...
V.F. Corporation (NYSE:VFC) Receives $16.21 Average Price Target from Analysts
V.F. Corporation (NYSE:VFC – Get Free Report) has received an average recommendation of “Hold” from the twenty-one ratings firms that...
Halliburton Company (NYSE:HAL) Receives $33.58 Average Price Target from Analysts
Shares of Halliburton Company (NYSE:HAL – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-one...
MSA Safety Incorporporated (NYSE:MSA) Upgraded by Wall Street Zen to Buy Rating
MSA Safety Incorporporated (NYSE:MSA – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold”...
Gates Industrial (NYSE:GTES) Stock Rating Lowered by Wall Street Zen
Gates Industrial (NYSE:GTES – Get Free Report) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy”...